Upper Limb Treatment With "Gloreha Aria" in the Hemiplegic Patients

Status Completed

Clinical Trial Summary

Stroke is one of the leading causes of death and disability and has been described as a worldwide epidemic (1). Stroke survivors are affected by impairments and limitations of cognitive, language, perceptual, sensory, and motor functions. After a stroke, patients can improve spontaneously within the first 3 months (2) and then more slowly in the following year. The first day, decreased oedema and partial reperfusion of the ischemic penumbra may possibly explain these phenomena, but the improvement of neurological deficit in the following weeks suggests plasticity phenomena and brain cortical reorganization (3). While most recovery is thought to be made in the first few weeks after stroke, patients may make improvements on functional tasks many months after having a stroke (4). Restoring arm and hand skill after a stroke remains challenging, even though stroke rehabilitation programs have proven partial efficacy Repetitive task training has been shown to be effective in some aspects of rehabilitation, such as improving walking distance and speed and improving upper limb function (5). In this project, the investigators will use "Gloreha ARIA" (7) a new sensor-based therapy device designed for motor recovery of impaired upper limb Gloreha Aria offers specific programs that help patients to move arm, wrist and fingers. Therapists can customize therapy by focusing on a specific motor task.

Clinical Trial Description

The hypothesis was that rehabilitation with this device could be not inferior in comparison with hands-on physiotherapy, in the reeducation of upper arm in the patient affected by stroke from cerebral ischemia or hemorrhage that had occurred ≤ 30 days before. The principle purpose of this study will be to evaluate: 1. The feasibility of this new device 2. Efficacy in improving arm function abilities in the rehabilitation of patients with stroke in the sub-acute phase. Post-stroke patients admitted for inpatient rehabilitation to the Neurological Rehabilitation will be screened for enrolment and randomized in a controlled trial. All the patients will be informed about the aim and experimental procedures before enrolment, thus written informed consent will be obtained from all of them. Patients included in the study will be randomly assigned to intervention or control group according to simple randomization technique (computerized random numbers). ;

Study Design

Related Conditions & MeSH terms

Arm Injuries
Hemiplegia
Hemiplegia and/or Hemiparesis Following Stroke
Paresis
Upper Extremity Injury

Clinical Trial Details

NCT number	NCT03738813
Study type	Interventional
Source	Istituti Clinici Scientifici Maugeri SpA
Contact
Status	Completed
Phase	N/A
Start date	July 1, 2018
Completion date	September 7, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05691673` - Upper Extremity Force-velocity Profile in Swimmers
Completed	`NCT03677778` - Interscalene Brachial Plexus Block Washout to Reverse Inadvertent Phrenic Nerve Blockade	N/A
Recruiting	`NCT04501510` - Ultrasonography in Fracture Management
Not yet recruiting	`NCT06356415` - Infraclavicular Brachial Plexus Block With Bupivacaine Alone or With Both Dexmedetomidine and Dexamethasone	N/A
Completed	`NCT05359731` - Pharmacokinetic Analysis of Bupivacaine in the Presence and Absence of Perineural Dexamethasone in Axillary Blockade	Phase 4
Completed	`NCT03807505` - Erector Spinae Plane Versus Interscalene Blocks for Shoulder Surgery	N/A
Recruiting	`NCT03595514` - Single Versus Double Injection Costoclavicular Block	N/A
Withdrawn	`NCT01605929` - Clinical Evaluation of the Ultrasound-Guided Retroclavicular Brachial Plexus Block	N/A
Recruiting	`NCT04994405` - Lower Tourniquet Pressure Study	N/A
Completed	`NCT04019990` - Throwers Ten Exercises On Upper Extremity Function and Explosive Power in Wheelchair Basketball and Basketball Players	N/A
Recruiting	`NCT03702387` - Evaluation of Second Esmarch Application on Intravenous Regional Anesthesia Effectiveness	N/A
Recruiting	`NCT05261425` - Suture Closure Trial	N/A
Completed	`NCT05476198` - Brachial Plexus Block vs. General Anesthesia for Anesthesia Anxiety Before Orthopedic Upper Extremity Surgery	N/A
Completed	`NCT05422989` - Public Health Risks and Characteristics of Upper Extremity Trauma During COVID-19
Not yet recruiting	`NCT06016647` - Multi-axis Assessment of Injured Workers
Completed	`NCT04875039` - Dexametasone Versus Dexametasone Plus Dexmedetomidine in Nerve Blocks	Phase 4
Completed	`NCT03610893` - Dexamethasone Versus Dexmedetomidine as Adjuvants for Nerve Blocks	N/A
Enrolling by invitation	`NCT05328934` - SoftHand Comparison Study	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.